We are live on ! Find out more
SEC

Seven Eight Capital Portfolio holdings

AUM $1.11B
1-Year Est. Return 29.48%
This Fund
S&P 500
This Quarter Est. Return
+32.93%
1 Year Est. Return
+29.48%
3 Year Est. Return
+13.61%
5 Year Est. Return
+117.69%
10 Year Est. Return
+239.1%
AUM
$137M
AUM Growth
-$252M
Cap. Flow
-$274M
Cap. Flow %
-200.36%
Top 10 Hldgs %
12.88%
Holding
642
New
208
Increased
25
Reduced
68
Closed
338

Top Buys

Rank Stock Value
1
CAG icon
Conagra Brands
CAG
+$2.84M
2
LHX icon
L3Harris
LHX
+$2.33M
3
XLNX
Xilinx Inc
XLNX
+$1.66M
4
BABA icon
Alibaba
BABA
+$1.46M
5
ZBH icon
Zimmer Biomet
ZBH
+$1.39M

Top Sells

Rank Stock Value
1
CRM icon
Salesforce
CRM
+$6.29M
2
ABT icon
Abbott
ABT
+$6.26M
3
V icon
Visa
V
+$6.25M
4
VZ icon
Verizon
VZ
+$6.22M
5
WFC icon
Wells Fargo
WFC
+$5.82M

Sector Composition

Rank Sector Weight
1 Technology 18.17%
2 Healthcare 14.15%
3 Industrials 11.71%
4 Consumer Discretionary 11.29%
5 Consumer Staples 10.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AIMT
626
DELISTED
Aimmune Therapeutics
AIMT
-29,200
Closed -$421K
TECD
627
DELISTED
Tech Data Corp
TECD
-4,600
Closed -$602K
LK
628
DELISTED
Luckin Coffee Inc. American Depositary Shares
LK
-56,000
Closed -$1.52M
AGN
629
DELISTED
Allergan plc
AGN
-12,300
Closed -$2.18M
MLNX
630
DELISTED
Mellanox Technologies, Ltd.
MLNX
-7,000
Closed -$849K
FTSV
631
DELISTED
Forty Seven, Inc. Common Stock
FTSV
-27,300
Closed -$2.6M
RTN
632
DELISTED
Raytheon Company
RTN
-6,700
Closed -$879K
RARX
633
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
-50,300
Closed -$2.42M
HZNP
634
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
-13,000
Closed -$385K
ZGNX
635
DELISTED
Zogenix, Inc.
ZGNX
-8,779
Closed -$217K
SIVB
636
DELISTED
SVB Financial Group
SIVB
-3,300
Closed -$499K
GRA
637
DELISTED
W.R. Grace & Co.
GRA
-10,900
Closed -$388K
CHL
638
DELISTED
China Mobile Limited
CHL
-12,000
Closed -$452K
STMP
639
DELISTED
Stamps.com, Inc.
STMP
-1,900
Closed -$247K
EE
640
DELISTED
El Paso Electric Company
EE
-12,800
Closed -$870K
CIT
641
DELISTED
CIT Group Inc.
CIT
-57,000
Closed -$984K
CADE
642
DELISTED
Cadence Bancorporation
CADE
-22,900
Closed -$150K

Similar funds

Seven Eight Capital's Q2 2020 Portfolio in Review

As of Q2 2020, Seven Eight Capital held 642 positions worth $137M, down 65% from $389M the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Seven Eight Capital withdrew a net $274M in Q2 2020, closing 338 positions and reducing 68 holdings. Its most notable exit was Salesforce, an estimated $6.29M position sold in full.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 23% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Seven Eight Capital opened a new position in Conagra Brands worth $2.99M.

  • Seven Eight Capital's largest Q2 2020 buy was Conagra Brands: 85,100 shares worth $2.99M.
  • Seven Eight Capital added most to Xilinx Inc in Q2 2020, an estimated $1.66M increase.
  • Seven Eight Capital's biggest Q2 2020 reduction was Chevron, cutting an estimated $5.48M.
  • Seven Eight Capital fully exited Salesforce in Q2 2020, selling an estimated $6.29M.
  • Seven Eight Capital's ten largest holdings make up 13% of its $137M portfolio in Q2 2020.
  • Seven Eight Capital opened 208 new positions and closed 338 in Q2 2020.
  • Seven Eight Capital's portfolio value fell 65% quarter-over-quarter to $137M.

Based on Seven Eight Capital's 13F filing for Q2 2020, filed 6 Aug 2020.